drugset / Trial / NCT02773576
Safety and Tolerability of Risperidone Implants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A one year, open-label, study to evaluate the safety and tolerability of risperidone implants as a maintenance treatment in patients with schizophrenia
Timeline
- Start
- 2016-04
- Primary completion
- 2017-09
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 300 mg | — |
| Subject | Risperidone | Other / unclassified | 360 mg | — |